nodes	percent_of_prediction	percent_of_DWPC	metapath
Travoprost—Hypotension—Azathioprine—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Travoprost—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Travoprost—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Travoprost—Discomfort—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Travoprost—Nervous system disorder—Leflunomide—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Travoprost—Pruritus—Mometasone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Travoprost—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Travoprost—Tachycardia—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Travoprost—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Travoprost—Skin disorder—Leflunomide—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Travoprost—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Travoprost—Abdominal pain—Captopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Travoprost—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Travoprost—Oedema—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Travoprost—Nausea—Pentoxifylline—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Travoprost—Malaise—Lisinopril—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Travoprost—Infection—Mycophenolic acid—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Travoprost—Vertigo—Lisinopril—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Travoprost—Diarrhoea—Mometasone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Travoprost—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Travoprost—Hypotension—Leflunomide—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Travoprost—Tachycardia—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Travoprost—Palpitations—Lisinopril—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Travoprost—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Travoprost—Skin disorder—Mycophenolic acid—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Travoprost—Cough—Lisinopril—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Travoprost—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Travoprost—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Travoprost—Chest pain—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Travoprost—Myalgia—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Travoprost—Arthralgia—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Travoprost—Anxiety—Lisinopril—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Travoprost—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Travoprost—Dyspnoea—Leflunomide—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Travoprost—Hypotension—Mycophenolic acid—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Travoprost—Discomfort—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Travoprost—Dyspepsia—Leflunomide—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Travoprost—Dry mouth—Lisinopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Travoprost—Feeling abnormal—Azathioprine—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Travoprost—Rash—Mometasone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Travoprost—Asthenia—Captopril—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Travoprost—Dermatitis—Mometasone—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Travoprost—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Travoprost—Headache—Mometasone—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Travoprost—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Travoprost—Fatigue—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Travoprost—Oedema—Lisinopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Travoprost—Pruritus—Captopril—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Travoprost—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Travoprost—Pain—Leflunomide—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Travoprost—Constipation—Leflunomide—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Travoprost—Infection—Lisinopril—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Travoprost—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.0011	0.0011	CcSEcCtD
Travoprost—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Travoprost—Tachycardia—Lisinopril—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Travoprost—Abdominal pain—Azathioprine—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Travoprost—Skin disorder—Lisinopril—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Travoprost—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Travoprost—Diarrhoea—Captopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Travoprost—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Travoprost—Feeling abnormal—Leflunomide—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Travoprost—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Travoprost—Fatigue—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Travoprost—Nausea—Mometasone—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Travoprost—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Travoprost—Pain—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Travoprost—Constipation—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Travoprost—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Travoprost—Cough—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Travoprost—Hypotension—Lisinopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Travoprost—Dizziness—Captopril—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Travoprost—Depression—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Travoprost—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Travoprost—Abdominal pain—Leflunomide—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Travoprost—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Travoprost—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Travoprost—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Travoprost—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Travoprost—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Travoprost—Hypersensitivity—Azathioprine—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Travoprost—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Travoprost—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Travoprost—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Travoprost—Dyspnoea—Lisinopril—systemic scleroderma	0.000991	0.000991	CcSEcCtD
Travoprost—Rash—Captopril—systemic scleroderma	0.00099	0.00099	CcSEcCtD
Travoprost—Dermatitis—Captopril—systemic scleroderma	0.000989	0.000989	CcSEcCtD
Travoprost—Headache—Captopril—systemic scleroderma	0.000984	0.000984	CcSEcCtD
Travoprost—Dyspepsia—Lisinopril—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Travoprost—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000976	0.000976	CcSEcCtD
Travoprost—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000974	0.000974	CcSEcCtD
Travoprost—Asthma—Methotrexate—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Travoprost—Infection—Mycophenolate mofetil—systemic scleroderma	0.000968	0.000968	CcSEcCtD
Travoprost—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Travoprost—Fatigue—Lisinopril—systemic scleroderma	0.000959	0.000959	CcSEcCtD
Travoprost—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000955	0.000955	CcSEcCtD
Travoprost—Hypersensitivity—Leflunomide—systemic scleroderma	0.000953	0.000953	CcSEcCtD
Travoprost—Pain—Lisinopril—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Travoprost—Constipation—Lisinopril—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Travoprost—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000951	0.000951	CcSEcCtD
Travoprost—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Travoprost—Bradycardia—Prednisone—systemic scleroderma	0.000946	0.000946	CcSEcCtD
Travoprost—Diarrhoea—Azathioprine—systemic scleroderma	0.000938	0.000938	CcSEcCtD
Travoprost—Nausea—Captopril—systemic scleroderma	0.000933	0.000933	CcSEcCtD
Travoprost—Asthenia—Leflunomide—systemic scleroderma	0.000928	0.000928	CcSEcCtD
Travoprost—Feeling abnormal—Lisinopril—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Travoprost—Pruritus—Leflunomide—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Travoprost—Connective tissue disorder—Prednisone—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Travoprost—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Travoprost—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000909	0.000909	CcSEcCtD
Travoprost—Dysuria—Methotrexate—systemic scleroderma	0.000907	0.000907	CcSEcCtD
Travoprost—Dizziness—Azathioprine—systemic scleroderma	0.000906	0.000906	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000888	0.000888	CcSEcCtD
Travoprost—Asthenia—Mycophenolic acid—systemic scleroderma	0.000886	0.000886	CcSEcCtD
Travoprost—Diarrhoea—Leflunomide—systemic scleroderma	0.000885	0.000885	CcSEcCtD
Travoprost—Abdominal pain—Lisinopril—systemic scleroderma	0.000879	0.000879	CcSEcCtD
Travoprost—Pruritus—Mycophenolic acid—systemic scleroderma	0.000873	0.000873	CcSEcCtD
Travoprost—Eye disorder—Prednisone—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Travoprost—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000869	0.000869	CcSEcCtD
Travoprost—Infestation—Methotrexate—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Travoprost—Infestation NOS—Methotrexate—systemic scleroderma	0.000865	0.000865	CcSEcCtD
Travoprost—Rash—Azathioprine—systemic scleroderma	0.000864	0.000864	CcSEcCtD
Travoprost—Dermatitis—Azathioprine—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Travoprost—Depression—Methotrexate—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Travoprost—Headache—Azathioprine—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Travoprost—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000858	0.000858	CcSEcCtD
Travoprost—Dizziness—Leflunomide—systemic scleroderma	0.000856	0.000856	CcSEcCtD
Travoprost—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000845	0.000845	CcSEcCtD
Travoprost—Angiopathy—Prednisone—systemic scleroderma	0.000843	0.000843	CcSEcCtD
Travoprost—Conjunctivitis—Methotrexate—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Travoprost—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000841	0.000841	CcSEcCtD
Travoprost—Immune system disorder—Prednisone—systemic scleroderma	0.00084	0.00084	CcSEcCtD
Travoprost—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Travoprost—Pain—Mycophenolate mofetil—systemic scleroderma	0.000833	0.000833	CcSEcCtD
Travoprost—Hypersensitivity—Lisinopril—systemic scleroderma	0.000819	0.000819	CcSEcCtD
Travoprost—Dizziness—Mycophenolic acid—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Travoprost—Rash—Leflunomide—systemic scleroderma	0.000816	0.000816	CcSEcCtD
Travoprost—Dermatitis—Leflunomide—systemic scleroderma	0.000815	0.000815	CcSEcCtD
Travoprost—Mental disorder—Prednisone—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Travoprost—Nausea—Azathioprine—systemic scleroderma	0.000814	0.000814	CcSEcCtD
Travoprost—Headache—Leflunomide—systemic scleroderma	0.000811	0.000811	CcSEcCtD
Travoprost—Erythema—Prednisone—systemic scleroderma	0.000809	0.000809	CcSEcCtD
Travoprost—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Travoprost—Asthenia—Lisinopril—systemic scleroderma	0.000798	0.000798	CcSEcCtD
Travoprost—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000797	0.000797	CcSEcCtD
Travoprost—Pruritus—Lisinopril—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Travoprost—Rash—Mycophenolic acid—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Travoprost—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Travoprost—Headache—Mycophenolic acid—systemic scleroderma	0.000773	0.000773	CcSEcCtD
Travoprost—Pharyngitis—Methotrexate—systemic scleroderma	0.000771	0.000771	CcSEcCtD
Travoprost—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00077	0.00077	CcSEcCtD
Travoprost—Nausea—Leflunomide—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Travoprost—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Travoprost—Vision blurred—Prednisone—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Travoprost—Urethral disorder—Methotrexate—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Travoprost—Diarrhoea—Lisinopril—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Travoprost—Ill-defined disorder—Prednisone—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Travoprost—Visual impairment—Methotrexate—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Travoprost—Dizziness—Lisinopril—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Travoprost—Nausea—Mycophenolic acid—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Travoprost—Malaise—Prednisone—systemic scleroderma	0.00073	0.00073	CcSEcCtD
Travoprost—Vertigo—Prednisone—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Travoprost—Eye disorder—Methotrexate—systemic scleroderma	0.000726	0.000726	CcSEcCtD
Travoprost—Tinnitus—Methotrexate—systemic scleroderma	0.000724	0.000724	CcSEcCtD
Travoprost—Cardiac disorder—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
Travoprost—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Travoprost—Angiopathy—Methotrexate—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Travoprost—Immune system disorder—Methotrexate—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Travoprost—Rash—Lisinopril—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Travoprost—Dermatitis—Lisinopril—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Travoprost—Mediastinal disorder—Methotrexate—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Travoprost—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Travoprost—Hypertension—Prednisone—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Travoprost—Headache—Lisinopril—systemic scleroderma	0.000697	0.000697	CcSEcCtD
Travoprost—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Travoprost—Arthralgia—Prednisone—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Travoprost—Myalgia—Prednisone—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Travoprost—Anxiety—Prednisone—systemic scleroderma	0.000686	0.000686	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Travoprost—Discomfort—Prednisone—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Travoprost—Mental disorder—Methotrexate—systemic scleroderma	0.000681	0.000681	CcSEcCtD
Travoprost—Erythema—Methotrexate—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Travoprost—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000667	0.000667	CcSEcCtD
Travoprost—Dysgeusia—Methotrexate—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Travoprost—Nausea—Lisinopril—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Travoprost—Oedema—Prednisone—systemic scleroderma	0.00066	0.00066	CcSEcCtD
Travoprost—Infection—Prednisone—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Travoprost—Back pain—Methotrexate—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Travoprost—Nervous system disorder—Prednisone—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Travoprost—Tachycardia—Prednisone—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Travoprost—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000644	0.000644	CcSEcCtD
Travoprost—Skin disorder—Prednisone—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Travoprost—Vision blurred—Methotrexate—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Travoprost—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Travoprost—Rash—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Travoprost—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Travoprost—Headache—Mycophenolate mofetil—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Travoprost—Malaise—Methotrexate—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Travoprost—Vertigo—Methotrexate—systemic scleroderma	0.000608	0.000608	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Travoprost—Cough—Methotrexate—systemic scleroderma	0.00059	0.00059	CcSEcCtD
Travoprost—Dyspepsia—Prednisone—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Travoprost—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Travoprost—Arthralgia—Methotrexate—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Travoprost—Chest pain—Methotrexate—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Travoprost—Myalgia—Methotrexate—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Travoprost—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Travoprost—Fatigue—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Travoprost—Discomfort—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Travoprost—Constipation—Prednisone—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Travoprost—Infection—Methotrexate—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Travoprost—Feeling abnormal—Prednisone—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Travoprost—Nervous system disorder—Methotrexate—systemic scleroderma	0.000541	0.000541	CcSEcCtD
Travoprost—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Travoprost—Skin disorder—Methotrexate—systemic scleroderma	0.000536	0.000536	CcSEcCtD
Travoprost—Abdominal pain—Prednisone—systemic scleroderma	0.000522	0.000522	CcSEcCtD
Travoprost—Hypotension—Methotrexate—systemic scleroderma	0.000516	0.000516	CcSEcCtD
Travoprost—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000503	0.000503	CcSEcCtD
Travoprost—Dyspnoea—Methotrexate—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Travoprost—Hypersensitivity—Prednisone—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Travoprost—Dyspepsia—Methotrexate—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Travoprost—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Travoprost—Fatigue—Methotrexate—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Travoprost—Asthenia—Prednisone—systemic scleroderma	0.000474	0.000474	CcSEcCtD
Travoprost—Pain—Methotrexate—systemic scleroderma	0.000472	0.000472	CcSEcCtD
Travoprost—Pruritus—Prednisone—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Travoprost—Feeling abnormal—Methotrexate—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Travoprost—Diarrhoea—Prednisone—systemic scleroderma	0.000452	0.000452	CcSEcCtD
Travoprost—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Travoprost—Dizziness—Prednisone—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Travoprost—Abdominal pain—Methotrexate—systemic scleroderma	0.000436	0.000436	CcSEcCtD
Travoprost—Rash—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Travoprost—Dermatitis—Prednisone—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Travoprost—Headache—Prednisone—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Travoprost—Hypersensitivity—Methotrexate—systemic scleroderma	0.000407	0.000407	CcSEcCtD
Travoprost—Asthenia—Methotrexate—systemic scleroderma	0.000396	0.000396	CcSEcCtD
Travoprost—Nausea—Prednisone—systemic scleroderma	0.000392	0.000392	CcSEcCtD
Travoprost—Pruritus—Methotrexate—systemic scleroderma	0.00039	0.00039	CcSEcCtD
Travoprost—Diarrhoea—Methotrexate—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Travoprost—Dizziness—Methotrexate—systemic scleroderma	0.000365	0.000365	CcSEcCtD
Travoprost—Rash—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Travoprost—Dermatitis—Methotrexate—systemic scleroderma	0.000348	0.000348	CcSEcCtD
Travoprost—Headache—Methotrexate—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Travoprost—Nausea—Methotrexate—systemic scleroderma	0.000328	0.000328	CcSEcCtD
